Cargando…

Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6‐Mediated Metabolic Activity

The cytochrome P450 2D6 (CYP2D6) gene locus is challenging to accurately genotype due to numerous single nucleotide variants and complex structural variation. Our goal was to determine whether the CYP2D6 genotype‐phenotype correlation is improved when diplotype assignments incorporate structural var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalton, Rachel, Lee, Seung‐been, Claw, Katrina G., Prasad, Bhagwat, Phillips, Brian R., Shen, Danny D., Wong, Lai Hong, Fade, Mitch, McDonald, Matthew G., Dunham, Maitreya J., Fowler, Douglas M., Rettie, Allan E., Schuetz, Erin, Thornton, Timothy A., Nickerson, Deborah A., Gaedigk, Andrea, Thummel, Kenneth E., Woodahl, Erica L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951848/ https://www.ncbi.nlm.nih.gov/pubmed/31536170 http://dx.doi.org/10.1111/cts.12695

Ejemplares similares

Transfer learning enables prediction of CYP2D6 haplotype function
por: McInnes, Gregory, et al.
Publicado: (2020)

Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a model
por: Lee, Seung-been, et al.
Publicado: (2018)

CYP2D7 Sequence Variation Interferes with TaqMan CYP2D6(*)15 and (*)35 Genotyping
por: Riffel, Amanda K., et al.
Publicado: (2016)

Characterization of complex structural variation in the CYP2D6-CYP2D7-CYP2D8 gene loci using single-molecule long-read sequencing
por: Turner, Amy J., et al.
Publicado: (2023)

Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment
por: Charoenchokthavee, Wanaporn, et al.
Publicado: (2016)

Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function
por: Fohner, Alison E., et al.
Publicado: (2021)

The Effect of Flavonoid Aglycones on the CYP1A2, CYP2A6, CYP2C8 and CYP2D6 Enzymes Activity
por: Bojić, Mirza, et al.
Publicado: (2019)

Methodology for clinical genotyping of CYP2D6 and CYP2C19
por: Carvalho Henriques, Beatriz, et al.
Publicado: (2021)

The Effects of H(2)S on the Activities of CYP2B6, CYP2D6, CYP3A4, CYP2C19 and CYP2C9 in Vivo in Rat
por: Wang, Xianqin, et al.
Publicado: (2013)

Effects of Saikosaponin D on CYP1A2 and CYP2D6 in HepaRG Cells
por: Li, Hongfang, et al.
Publicado: (2020)

A longitudinal study of cytochrome P450 2D6 (CYP2D6) activity during adolescence
por: Leeder, J. Steven, et al.
Publicado: (2022)

Prediction of CYP2D6 phenotype from genotype across world populations
por: Gaedigk, Andrea, et al.
Publicado: (2017)

Correction: Methodology for clinical genotyping of CYP2D6 and CYP2C19
por: Henriques, Beatriz Carvalho, et al.
Publicado: (2022)

The Evaluation of CYP2D6, CYP2C9, CYP2C19, and CYP2B6 Phenoconversion in Post-Mortem Casework: The Challenge of Forensic Toxicogenetics
por: Giorgetti, Arianna, et al.
Publicado: (2023)

Functional characterization of novel rare CYP2A6 variants and potential implications for clinical outcomes
por: El‐Boraie, Ahmed, et al.
Publicado: (2021)

Expression of CYP2A6, CYP2D6 and CYP4A11 Polymorphisms in COS7 Mammalian Cell Line
por: Lee, Hye Ja, et al.
Publicado: (2011)

CYP2D6 genotype and tamoxifen response
por: Rae, James M, et al.
Publicado: (2005)

The impact of CYP2D6*41 on CYP2D6 enzyme activity using phenotyping methods in urine, plasma, and saliva
por: Jin, Ye, et al.
Publicado: (2022)

Identification of Novel CYP2D7-2D6 Hybrids: Non-Functional and Functional Variants
por: Gaedigk, Andrea, et al.
Publicado: (2010)

Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19
por: Swen, J. J., et al.
Publicado: (2011)

Comparison of Paeoniflorin and Albiflorin on Human CYP3A4 and CYP2D6
por: Gao, Li-Na, et al.
Publicado: (2015)

Genetic analysis of the equine orthologues for human CYP2D6: unraveling the complexity of the CYP2D family in horses
por: Scantamburlo, Giada, et al.
Publicado: (2023)

Enantioselective pharmacokinetics of tramadol and its three main metabolites; impact of CYP2D6, CYP2B6, and CYP3A4 genotype
por: Haage, Pernilla, et al.
Publicado: (2018)

CYP2D6 Genetic Variation and Its Implication for Vivax Malaria Treatment in Madagascar
por: Mehlotra, Rajeev K., et al.
Publicado: (2021)

Ten Years’ Experience with the CYP2D6 Activity Score: A Perspective on Future Investigations to Improve Clinical Predictions for Precision Therapeutics
por: Gaedigk, Andrea, et al.
Publicado: (2018)

Effects of rolapitant administered orally on the pharmacokinetics of dextromethorphan (CYP2D6), tolbutamide (CYP2C9), omeprazole (CYP2C19), efavirenz (CYP2B6), and repaglinide (CYP2C8) in healthy subjects
por: Wang, Jing, et al.
Publicado: (2018)

Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19
por: Koopmans, Anne B., et al.
Publicado: (2021)

The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses
por: Kee, Ping Siu, et al.
Publicado: (2023)

The Impact of CYP2D6 Genotyping on Tamoxifen Treatment
por: Ferraldeschi, Roberta, et al.
Publicado: (2010)

Enantioselective metabolism of primaquine by human CYP2D6
por: Fasinu, Pius S, et al.
Publicado: (2014)

CYP2D6 polymorphisms and their influence on risperidone treatment
por: Puangpetch, Apichaya, et al.
Publicado: (2016)

Quasi-Irreversible Inhibition of CYP2D6 by Berberine
por: Kim, Ha Gyeong, et al.
Publicado: (2020)

Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites—a study in 839 patients with known CYP2D6 genotype
por: Wollmann, Birgit M., et al.
Publicado: (2023)

Association of CYP2C19, CYP2D6 and CYP3A4 Genetic Variants on Primaquine Hemolysis in G6PD-Deficient Patients
por: Macêdo, Marielle M., et al.
Publicado: (2023)

Characterization of Novel CYP2D6 Alleles across Sub-Saharan African Populations
por: Wang, Wendy Y., et al.
Publicado: (2022)

CYP2D6 GENOTYPE AND REDUCED CODEINE ANALGESIC EFFECT IN REAL-WORLD CLINICAL PRACTICE
por: Carranza-Leon, Daniel, et al.
Publicado: (2021)

Pediatric CYP2D6 metabolizer status and post‐tonsillectomy nausea and vomiting after ondansetron
por: Black, Katherine, et al.
Publicado: (2022)

Simple and Robust Detection of CYP2D6 Gene Deletions and Duplications Using CYP2D8P as Reference
por: Larsen, Jens Borggaard, et al.
Publicado: (2022)

CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial
por: Smith, D. Max, et al.
Publicado: (2019)

Prescribed Doses of CYP2D6-Metabolized Drugs and Hemodynamic Responses in Relation to CYP2D6 Genotype Among Older Patients Exposed to Polypharmacy
por: Romskaug, Rita, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5d68sc1q3c43vjqbl017fh432f